Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-22

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide for treating hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)